Half-year report · Q2
6894.TEDINET S100URYW
Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥972m | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥2.6bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥993m | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥56m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥69m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥53m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥387m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥88m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥39m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥112m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥25m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥327m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥76m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥25m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥76m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥4.4bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥5.2bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥4.5bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥907m | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥1.5bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.5bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥3.7bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.4bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.8bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.3bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.7bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.0bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥157m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥399m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥174m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥247m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥89m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥40m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥154m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥146m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥140m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥18.55 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥238.99 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.77 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 79.6% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.9% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.2% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥375m |
| jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥375m |
| jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥37m |
| jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥353m |
| jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥353m |
| jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥100m |
| jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥244m |
| jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥244m |
| jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥70m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥972m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥972m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥207m |
| jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥332m |
| jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥332m |
| jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥9m |
| jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥345m |
| jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥345m |
| jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥103m |
| jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥317m |
| jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥317m |
| jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥110m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥993m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥993m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥222m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 432
| Item | Context | Value | Unit |
|---|---|---|---|
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 2763000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 3886000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -129000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -66000 | JPY |
| Income taxes paid refund ope cf | Prior1YTDDuration | 5743000 | JPY |
| Income taxes paid refund ope cf | CurrentYTDDuration | -112604000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | 174038000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | -157238000 | JPY |
| Payments into time deposits inv cf | Prior1YTDDuration | － | JPY |
| Payments into time deposits inv cf | CurrentYTDDuration | -70118000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -36369000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -175703000 | JPY |
| Purchase of intangible assets inv cf | Prior1YTDDuration | － | JPY |
| Purchase of intangible assets inv cf | CurrentYTDDuration | -1270000 | JPY |
| Proceeds from cancellation of insurance funds inv cf | Prior1YTDDuration | 77416000 | JPY |
| Proceeds from cancellation of insurance funds inv cf | CurrentYTDDuration | － | JPY |
| Other net inv cf | Prior1YTDDuration | -978000 | JPY |
| Other net inv cf | CurrentYTDDuration | 119000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | 40068000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -246972000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -45160000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -5160000 | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | -110000 | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -144000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -94354000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -148361000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -139625000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -153665000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 9707000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | -12992000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 84189000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | -570869000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 1911128000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 2267271000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 1995317000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 1696402000 | JPY |
| Payroll and allowances sga | Prior1YTDDuration | 93650000 | JPY |
| Payroll and allowances sga | CurrentYTDDuration | 86089000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 14966000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 12968000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 6172000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 5109000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02021-000XRayResidualStressAnalyzerReportableSegmentMember | 316777000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02021-000HealthcareRelatedProductsReportableSegmentMember | 331765000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02021-000OpticalApplicationsAndSpecialCustomizedProductsReportableSegmentMember | 344877000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 993420000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02021-000XRayResidualStressAnalyzerReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02021-000HealthcareRelatedProductsReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02021-000OpticalApplicationsAndSpecialCustomizedProductsReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |